Approval given for AstraZeneca vaccine to be manufactured in Australia The Therapeutic Goods Administration has approved manufacture of the AstraZeneca COVID-19 Vaccine (ChAdOx1-S) in Australia. This follows on from the 16 February 2021 approval by TGA of the overseas-manufactured AstraZeneca vaccine. The vaccine will be manufactured in Australia by CSL - Seqirus, following "extensive work
This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.